Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $2,440 - $2,662
-33 Reduced 0.37%
9,000 $674,000
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $2,508 - $2,861
33 Added 0.37%
9,033 $696,000
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $116,824 - $146,393
-2,017 Reduced 18.31%
9,000 $535,000
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $50,985 - $58,095
-900 Reduced 7.55%
11,017 $642,000
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $1,229 - $1,428
17 Added 0.14%
11,917 $917,000
Q1 2020

May 13, 2020

BUY
$62.63 - $80.22 $56,367 - $72,198
900 Added 8.18%
11,900 $890,000
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $12,502 - $13,800
-200 Reduced 1.79%
11,000 $697,000
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $74,244 - $83,256
1,200 Added 12.0%
11,200 $757,000
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $625,300 - $700,500
10,000 New
10,000 $650,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.